Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Cancer|May 18, 2010
Emergence of potential biomarkers of response to anti-angiogenic anti-tumour agentsAgnieszka Michael, Kate Relph, Hardev Pandha
Expert Review of Vaccines|March 19, 2013
Prostate cancer vaccinesAgnieszka Michael, Kate Relph, Nicola Annels, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus: Using a Bladder Tumor Precision-Cut Slice Model System to Assess Viral EfficacyKate Relph, Nicola Annels, Chris Smith, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2023
Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysis by Coxsackie Virus A21Kate Relph, Mehreen Arif, Hardev Pandha, et al.
Oncolytic Virotherapy|September 1, 2016
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesGuy R Simpson, Kate Relph, Kevin Harrington, et al.
The Journal of Urology|October 31, 2006
Antitumor effects of aminobisphosphonates on renal cell carcinoma cell linesHardev Pandha, Lindsay Birchall, Brendan Meyer, et al.
Cancer Gene Therapy|May 4, 2018
Synergistic antitumour effects of rapamycin and oncolytic reovirusCharles Comins, Guy Richard Simpson, William Rogers, et al.
BJU International|July 10, 2007
Prognostic significance of erythropoietin expression in human renal cell carcinomaAgniezka Michael, Ekaterini Politi, Erik Havranek, et al.
Cancers|February 25, 2022
A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal AdenocarcinomaNabeel Merali, Tarak Chouari, Kayani Kayani, et al.
Pageof 1